E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/16/2006 in the Prospect News Biotech Daily.

Amazon Biotech appoints new financial, business adviser

By Elaine Rigoli

Tampa, Fla., Aug. 16 - Amazon Biotech, Inc. said Wednesday that it has signed a letter of agreement with Rohit Phansalkar to serve as business and financial adviser to help improve the structure and capital position of the company.

Phansalkar previously worked at Oppenheimer & Co., Shearson American Express and Bear Stearns & Co.

Phansalkar has also served as the chairman and chief executive officer of Osicom Technologies, chairman of The India Fund, vice chairman and chief executive officer of Newbridge (India) and as a director of several companies.

New York-based Amazon Biotech is a natural plant pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.